Loading…

Pharmacological Treatments for Autism Spectrum Disorder: Will Emerging Approaches Yield New Treatments?

Saved in:

Bibliographic Details
Published in:	Neuropsychopharmacology (New York, N.Y.) N.Y.), 2016-01, Vol.41 (1), p.376-377
Main Authors:	Gogliotti, Rocco G, Conn, P Jeffrey
Format:	Article
Language:	English
Subjects:	Animals Autism Autism Spectrum Disorder - genetics Autism Spectrum Disorder - metabolism Autism Spectrum Disorder - therapy Behavior Clinical trials Drug Delivery Systems - trends Genetic Therapy - trends Hot Topics Humans Insulin-Like Growth Factor I - pharmacology Insulin-Like Growth Factor I - therapeutic use Neurosciences Protein synthesis Proteins Receptor, Metabotropic Glutamate 5 - antagonists & inhibitors Receptor, Metabotropic Glutamate 5 - metabolism Receptors, GABA-B - metabolism Treatment Outcome
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by	cdi_FETCH-LOGICAL-c438t-a9ac5530a3f460af4da18af995dc5d5ea350cbe4c48fead4f062546e353cb9bd3
cites	cdi_FETCH-LOGICAL-c438t-a9ac5530a3f460af4da18af995dc5d5ea350cbe4c48fead4f062546e353cb9bd3
container_end_page	377
container_issue	1
container_start_page	376
container_title	Neuropsychopharmacology (New York, N.Y.)
container_volume	41
creator	Gogliotti, Rocco G Conn, P Jeffrey
description
doi_str_mv	10.1038/npp.2015.259
format	article
fullrecord	<record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4677143</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3890483281</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-a9ac5530a3f460af4da18af995dc5d5ea350cbe4c48fead4f062546e353cb9bd3</originalsourceid><addsrcrecordid>eNpdkU1v1DAQhi0EokvhxhlZ4sKBLHb8kZgDaFVaWqkCJIooJ2vWmWRdJXGwExD_vl61VIXTHObROx8PIc85W3Mm6jfjNK1LxtW6VOYBWfFKskILefmQrFhtRMGFuDwgT1K6YpmqdP2YHJRaq8ootSLdlx3EAVzoQ-cd9PQiIswDjnOibYh0s8w-DfTrhG6Oy0A_-BRig_Et_e77nh4PGDs_dnQzTTGA22GiPzz2Df2Ev-9lvX9KHrXQJ3x2Ww_Jt5Pji6PT4vzzx7OjzXnhpKjnAgw4pQQD0UrNoJUN8BpaY1TjVKMQhGJui9LJukVoZMt0qaRGoYTbmm0jDsm7m9xp2Q7YuDw8Qm-n6AeIf2wAb__tjH5nu_DLSl1VXIoc8Oo2IIafC6bZDj457HsYMSzJ5v8azUteq4y-_A-9Cksc83l7qhKyNIJl6vUN5WJIKWJ7twxndm_QZoN2b9Bmgxl_cf-AO_ivMnENL2mZ8g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1747342930</pqid></control><display><type>article</type><title>Pharmacological Treatments for Autism Spectrum Disorder: Will Emerging Approaches Yield New Treatments?</title><source>Open Access: PubMed Central</source><creator>Gogliotti, Rocco G ; Conn, P Jeffrey</creator><creatorcontrib>Gogliotti, Rocco G ; Conn, P Jeffrey</creatorcontrib><identifier>ISSN: 0893-133X</identifier><identifier>EISSN: 1740-634X</identifier><identifier>DOI: 10.1038/npp.2015.259</identifier><identifier>PMID: 26657955</identifier><identifier>CODEN: NEROEW</identifier><language>eng</language><publisher>England: Nature Publishing Group</publisher><subject>Animals ; Autism ; Autism Spectrum Disorder - genetics ; Autism Spectrum Disorder - metabolism ; Autism Spectrum Disorder - therapy ; Behavior ; Clinical trials ; Drug Delivery Systems - trends ; Genetic Therapy - trends ; Hot Topics ; Humans ; Insulin-Like Growth Factor I - pharmacology ; Insulin-Like Growth Factor I - therapeutic use ; Neurosciences ; Protein synthesis ; Proteins ; Receptor, Metabotropic Glutamate 5 - antagonists & inhibitors ; Receptor, Metabotropic Glutamate 5 - metabolism ; Receptors, GABA-B - metabolism ; Treatment Outcome</subject><ispartof>Neuropsychopharmacology (New York, N.Y.), 2016-01, Vol.41 (1), p.376-377</ispartof><rights>Copyright Nature Publishing Group Jan 2016</rights><rights>Copyright © 2016 American College of Neuropsychopharmacology 2016 American College of Neuropsychopharmacology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-a9ac5530a3f460af4da18af995dc5d5ea350cbe4c48fead4f062546e353cb9bd3</citedby><cites>FETCH-LOGICAL-c438t-a9ac5530a3f460af4da18af995dc5d5ea350cbe4c48fead4f062546e353cb9bd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677143/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677143/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26657955$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gogliotti, Rocco G</creatorcontrib><creatorcontrib>Conn, P Jeffrey</creatorcontrib><title>Pharmacological Treatments for Autism Spectrum Disorder: Will Emerging Approaches Yield New Treatments?</title><title>Neuropsychopharmacology (New York, N.Y.)</title><addtitle>Neuropsychopharmacology</addtitle><subject>Animals</subject><subject>Autism</subject><subject>Autism Spectrum Disorder - genetics</subject><subject>Autism Spectrum Disorder - metabolism</subject><subject>Autism Spectrum Disorder - therapy</subject><subject>Behavior</subject><subject>Clinical trials</subject><subject>Drug Delivery Systems - trends</subject><subject>Genetic Therapy - trends</subject><subject>Hot Topics</subject><subject>Humans</subject><subject>Insulin-Like Growth Factor I - pharmacology</subject><subject>Insulin-Like Growth Factor I - therapeutic use</subject><subject>Neurosciences</subject><subject>Protein synthesis</subject><subject>Proteins</subject><subject>Receptor, Metabotropic Glutamate 5 - antagonists & inhibitors</subject><subject>Receptor, Metabotropic Glutamate 5 - metabolism</subject><subject>Receptors, GABA-B - metabolism</subject><subject>Treatment Outcome</subject><issn>0893-133X</issn><issn>1740-634X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNpdkU1v1DAQhi0EokvhxhlZ4sKBLHb8kZgDaFVaWqkCJIooJ2vWmWRdJXGwExD_vl61VIXTHObROx8PIc85W3Mm6jfjNK1LxtW6VOYBWfFKskILefmQrFhtRMGFuDwgT1K6YpmqdP2YHJRaq8ootSLdlx3EAVzoQ-cd9PQiIswDjnOibYh0s8w-DfTrhG6Oy0A_-BRig_Et_e77nh4PGDs_dnQzTTGA22GiPzz2Df2Ev-9lvX9KHrXQJ3x2Ww_Jt5Pji6PT4vzzx7OjzXnhpKjnAgw4pQQD0UrNoJUN8BpaY1TjVKMQhGJui9LJukVoZMt0qaRGoYTbmm0jDsm7m9xp2Q7YuDw8Qm-n6AeIf2wAb__tjH5nu_DLSl1VXIoc8Oo2IIafC6bZDj457HsYMSzJ5v8azUteq4y-_A-9Cksc83l7qhKyNIJl6vUN5WJIKWJ7twxndm_QZoN2b9Bmgxl_cf-AO_ivMnENL2mZ8g</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Gogliotti, Rocco G</creator><creator>Conn, P Jeffrey</creator><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160101</creationdate><title>Pharmacological Treatments for Autism Spectrum Disorder: Will Emerging Approaches Yield New Treatments?</title><author>Gogliotti, Rocco G ; Conn, P Jeffrey</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-a9ac5530a3f460af4da18af995dc5d5ea350cbe4c48fead4f062546e353cb9bd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Autism</topic><topic>Autism Spectrum Disorder - genetics</topic><topic>Autism Spectrum Disorder - metabolism</topic><topic>Autism Spectrum Disorder - therapy</topic><topic>Behavior</topic><topic>Clinical trials</topic><topic>Drug Delivery Systems - trends</topic><topic>Genetic Therapy - trends</topic><topic>Hot Topics</topic><topic>Humans</topic><topic>Insulin-Like Growth Factor I - pharmacology</topic><topic>Insulin-Like Growth Factor I - therapeutic use</topic><topic>Neurosciences</topic><topic>Protein synthesis</topic><topic>Proteins</topic><topic>Receptor, Metabotropic Glutamate 5 - antagonists & inhibitors</topic><topic>Receptor, Metabotropic Glutamate 5 - metabolism</topic><topic>Receptors, GABA-B - metabolism</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gogliotti, Rocco G</creatorcontrib><creatorcontrib>Conn, P Jeffrey</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medicine (ProQuest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Psychology</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gogliotti, Rocco G</au><au>Conn, P Jeffrey</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacological Treatments for Autism Spectrum Disorder: Will Emerging Approaches Yield New Treatments?</atitle><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle><addtitle>Neuropsychopharmacology</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>41</volume><issue>1</issue><spage>376</spage><epage>377</epage><pages>376-377</pages><issn>0893-133X</issn><eissn>1740-634X</eissn><coden>NEROEW</coden><cop>England</cop><pub>Nature Publishing Group</pub><pmid>26657955</pmid><doi>10.1038/npp.2015.259</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0893-133X
ispartof	Neuropsychopharmacology (New York, N.Y.), 2016-01, Vol.41 (1), p.376-377
issn	0893-133X 1740-634X
language	eng
recordid	cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4677143
source	Open Access: PubMed Central
subjects	Animals Autism Autism Spectrum Disorder - genetics Autism Spectrum Disorder - metabolism Autism Spectrum Disorder - therapy Behavior Clinical trials Drug Delivery Systems - trends Genetic Therapy - trends Hot Topics Humans Insulin-Like Growth Factor I - pharmacology Insulin-Like Growth Factor I - therapeutic use Neurosciences Protein synthesis Proteins Receptor, Metabotropic Glutamate 5 - antagonists & inhibitors Receptor, Metabotropic Glutamate 5 - metabolism Receptors, GABA-B - metabolism Treatment Outcome
title	Pharmacological Treatments for Autism Spectrum Disorder: Will Emerging Approaches Yield New Treatments?
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T08%3A13%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacological%20Treatments%20for%20Autism%20Spectrum%20Disorder:%20Will%20Emerging%20Approaches%20Yield%20New%20Treatments?&rft.jtitle=Neuropsychopharmacology%20(New%20York,%20N.Y.)&rft.au=Gogliotti,%20Rocco%20G&rft.date=2016-01-01&rft.volume=41&rft.issue=1&rft.spage=376&rft.epage=377&rft.pages=376-377&rft.issn=0893-133X&rft.eissn=1740-634X&rft.coden=NEROEW&rft_id=info:doi/10.1038/npp.2015.259&rft_dat=%3Cproquest_pubme%3E3890483281%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c438t-a9ac5530a3f460af4da18af995dc5d5ea350cbe4c48fead4f062546e353cb9bd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1747342930&rft_id=info:pmid/26657955&rfr_iscdi=true